Wiley · Cell metabolism 2016 · In vitro and in vivo animal mechanistic study · n=?

Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype.

Cited 1243 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Preclinical laboratory research (human cell cultures and progeroid mouse model)

PubMed 26686024 · doi:10.1016/j.cmet.2015.11.011 · record verified 2026-08-30

What was done

Researchers compromised mitochondrial function in proliferating human cell cultures to assess effects on cell cycle arrest and the senescence-associated secretory phenotype (SASP). They examined the metabolic and signaling pathway involving NAD+/NADH ratios, AMPK, and p53. They also evaluated senescent cell accumulation in progeroid mice that rapidly accumulate mitochondrial DNA mutations and measured the effects of this secretome on adipogenesis and keratinocyte differentiation in culture.

What was found

Mitochondrial dysfunction caused a distinct senescence growth arrest (mitochondrial dysfunction-associated senescence, or MiDAS) that lacked the IL-1-dependent inflammatory arm typical of classical SASP. This phenotype was driven by lower NAD+/NADH ratios, which enforced growth arrest and blocked IL-1-related SASP through AMPK-mediated p53 activation. Progeroid mice accumulated MiDAS cells in vivo, and the resulting secretory profile suppressed adipogenesis and promoted keratinocyte differentiation in vitro. The abstract reports no numerical values or statistical effect sizes.

Why it matters

The findings identify a unique form of cellular senescence linked directly to cellular metabolic state and mitochondrial integrity, offering a mechanistic link between mitochondrial decline and age-related tissue dysfunction.

Limits

The abstract reports no sample sizes, effect sizes, or quantitative data. Evidence is limited to cell culture models and progeroid mice, which may not directly reflect the complexity of natural human aging.

Cited by